The American Journal of Managed Care and the Robert Wood Johnson Foundation will host a Tweetchat September 29 from 11 am to noon EDT on the Culture of Health and the impact of accountable care organizations (ACOs).
FOR IMMEDIATE RELEASESEPTEMBER 22, 2015
Incentives included in the Affordable Care Act have encouraged medical centers, clinics, and practitioners to create integrated healthcare entities that will move the US healthcare system away from fee-for-service. Accountable care organizations (ACOs), designed to improve quality of care and affordability, play a large role in this transformation.
On Tuesday, September 29, from 11 am to noon EDT, The American Journal of Managed Care (AJMC) will host a tweetchat with the Robert Wood Johnson Foundation (RWJF) about the impact of ACOs and RWJF’s efforts to build a national Culture of Health.
Andrea M. Ducas, MPH, a program officer with RWJF, will answer discuss topics that include promoting a Culture of Health, how ACOs impact healthcare quality and value, and the challenges facing ACOs. AJMC encourages Twitter users to submit questions and participate in the chat by using #AJMCchat. And don’t forget to follow @AJMC_Journal, @RWJF, and @AndreaDucas.
RWJF President and Chief Executive Officer Risa Lavizzo-Mourey, MD, MBA, wrote a special guest commentary for AJMC in July highlighting the role ACOs play in building a Culture of Health in which every person in America can have the healthiest life possible.
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
About Robert Wood Johnson Foundation
For more than 40 years the Robert Wood Johnson Foundation has worked to improve health and health care. We are striving to build a national Culture of Health that will enable all to live longer, healthier lives now and for generations to come. For more information, visithttp://www.rwjf.org. Follow the Foundation on Twitter at http://www.rwjf.org/twitter or on Facebook at http://www.rwjf.org/facebook.
Contact:
Nicole Beagin (609) 716-7777 x 131
nbeagin(at)ajmc(dot)com
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More